Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Shares Outstanding (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Shares Outstanding for 15 consecutive years, with $79.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding rose 4.75% to $79.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $79.6 million, a 4.75% increase, with the full-year FY2024 number at $77.3 million, up 3.13% from a year prior.
  • Shares Outstanding was $79.6 million for Q3 2025 at Niagen Bioscience, roughly flat from $79.6 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $79.6 million in Q3 2025 to a low of $67.7 million in Q1 2021.
  • A 5-year average of $73.3 million and a median of $74.9 million in 2023 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: grew 13.58% in 2021, then increased 0.11% in 2022.
  • Niagen Bioscience's Shares Outstanding stood at $68.1 million in 2021, then grew by 9.45% to $74.6 million in 2022, then rose by 0.56% to $75.0 million in 2023, then increased by 3.13% to $77.3 million in 2024, then increased by 2.99% to $79.6 million in 2025.
  • Per Business Quant, the three most recent readings for NAGE's Shares Outstanding are $79.6 million (Q3 2025), $79.6 million (Q2 2025), and $78.4 million (Q1 2025).